A severity scale for Age-Related Macular Degeneration (AMD)
Go back to Resources
A severity scale for Age-Related Macular Degeneration (AMD)
Authors:
Location:
Go back to ResourcesA Study to investigate the Safety and Efficacy of Daclizumab to treat the ocular complications related to the Behcet’s disease
Go back to Resources
A Study to investigate the Safety and Efficacy of Daclizumab to treat the ocular complications related to the Behcet’s disease
Authors:
Location:
Go back to ResourcesAREDS Update I: The effect of cataract surgery on progression to advanced AMD
Go back to Resources
AREDS Update I: The effect of cataract surgery on progression to advanced AMD
Authors:
Location:
Go back to ResourcesAREDS Update II: Mortality and Nutritional Risk Factors
Go back to Resources
AREDS Update II: Mortality and Nutritional Risk Factors
Authors:
Location:
Go back to ResourcesNo Benefit of 1log T-cell Depletion on Chronic Graft vs Host Disease (cGVHD):Results of a Multi-Center Randomized Trial in 404 Recipients of Unrelated Donor Bone Marrow Transplantation (UBMT)
Go back to Resources
No Benefit of 1log T-cell Depletion on Chronic Graft vs Host Disease (cGVHD):Results of a Multi-Center Randomized Trial in 404 Recipients of Unrelated Donor Bone Marrow Transplantation (UBMT)
Authors:
Location:
Go back to ResourcesNo Changes in Immune Activation Phenotypes, Response to Antigen, or CD8+ T-cell Mediated HIV Suppression in Transplant Recipients Receiving Immunosuppression
Go back to Resources
No Changes in Immune Activation Phenotypes, Response to Antigen, or CD8+ T-cell Mediated HIV Suppression in Transplant Recipients Receiving Immunosuppression
Authors:
Location:
Go back to ResourcesNot simply a matter of faulty memory: obstacles to implementing cognitive function ancillary studies in clinical trials with other primary outcomes
Go back to Resources
Not simply a matter of faulty memory: obstacles to implementing cognitive function ancillary studies in clinical trials with other primary outcomes
Authors:
Location:
Go back to ResourcesOngoing Prospective Multi-Center Safety Study of Subcutaneous Cytoprotectant Amifostine
Go back to Resources
Ongoing Prospective Multi-Center Safety Study of Subcutaneous Cytoprotectant Amifostine
Authors:
Location:
Go back to ResourcesPalivizumab prophylaxis of respiratory syncytial virus (RSV) - results from the 2000-2001 Synagis Outcomes Registry
Go back to Resources
Palivizumab prophylaxis of respiratory syncytial virus (RSV) - results from the 2000-2001 Synagis Outcomes Registry
Authors:
Secondary:
Volume:
Pagination:
Palivizumab prophylaxis of RSV disease: demographic and risk factors results from the 2002-2003 Outcomes Registry
Go back to Resources
Palivizumab prophylaxis of RSV disease: demographic and risk factors results from the 2002-2003 Outcomes Registry
Authors:
Location:
Go back to Resources